T1	Participants 393 513	centres of five of the countries participating in the European Randomized Study of Screening for Prostate Cancer (ERSPC)
T2	Participants 78 151	cancer in the European Randomized Study of Screening for Prostate Cancer.
T3	Participants 706 859	56,653 screened men in the ERSPC centres of Finland, Italy, Netherlands, Sweden and Switzerland, who underwent 3-7 screening rounds at 2-4 year interval.
